VAV3 mediates resistance to breast cancer endocrine therapy
Helena Aguilar, Ander Urruticoechea, Pasi Halonen, Kazuma Kiyotani, Taisei Mushiroda, Xavier Barril, Jordi Serra-Musach, Abul Bashar Mir Md. Khademul Islam, Livia Caizzi, Luciano Di Croce, Ekaterina Nevedomskaya, Wilbert Zwart, Josefine Bostner, Elin Karlsson, G. Pérez Tenorio, Tommy� Fornander, Dennis C. Sgroi, Rafael Garcı́a-Mata, Maurice P.H.M. Jansen, Nadia García, Núria Bonifaci, Fina Climent, María Teresa Soler, Alejo Rodríguez‐Vida, Miguel Ángel Cobos Gil, Joan Brunet, Griselda Martrat, Laia Gómez‐Baldó, Ana I. Extremera, Albert Figueras, Josep Balart, Robert Clarke, Kerry L. Burnstein, Kathryn E. Carlson, John A. Katzenellenbogen, Miguel Vizoso, Manel Esteller, Alberto Villanueva, Ana B. Rodríguez-Peña, Xosé R. Bustelo, Yusuke Nakamura, Hitoshi Zembutsu, Olle Stål, Roderick L. Beijersbergen, Miguel Ángel Pujana (2014). VAV3 mediates resistance to breast cancer endocrine therapy. , 16(3), DOI: https://doi.org/10.1186/bcr3664.
